Based on immunohistochemical staining, the phenotype of the tumor cells was CD3+, CD43+, CD56+, TIA-1+, CD30+, CD4-, CD5-, CD7-, CD8-, CD20- and CD79a-. This evidence concerns the gene CD5 and neoplasm.